P2 purinergic receptors on osteoblasts and osteoclasts: Potential targets for drug development

Drug Development Research

Volumn 49, Issue 3, 2000, Pages 187-200

  Dixon, S Jeffrey ^a   Sims, Stephen M ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Bisphosphonate; Ion channel; Mechanotransduction; Nucleotide; Purinoceptor

Indexed keywords

4,4' DIISOTHIOCYANATOSTILBENE 2,2' DISULFONIC ACID; ALENDRONIC ACID; ANABOLIC AGENT; BETA,GAMMA DICHLOROMETHYLENE ADENOSINE TRIPHOSPHATE; BETA,GAMMA METHYLENEADENOSINE TRIPHOSPHATE; BISPHOSPHONIC ACID DERIVATIVE; CIBACRON BLUE F3GA; CLODRONIC ACID; FPL 66096; PARATHYROID HORMONE; PURINE P2 RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; PURINERGIC RECEPTOR STIMULATING AGENT; PYRIDOXAL PHOSPHATE 6 AZOPHENYL 2',4' DISULFONIC ACID; RECEPTOR SUBTYPE; RISEDRONIC ACID; SURAMIN; UNCLASSIFIED DRUG;

AUTOCRINE EFFECT; BONE METABOLISM; CANCER; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG RESEARCH; DRUG STRUCTURE; DRUG TARGETING; HUMAN; MECHANICAL STIMULATION; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; OSTEOPOROSIS; PARACRINE SIGNALING; PERIODONTITIS; PROTEIN EXPRESSION; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; THROMBOSIS; TRYPANOSOMIASIS;

EID: 0034081759     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2299(200003)49:3<187::AID-DDR9>3.0.CO;2-F     Document Type: Review

References (86)

1. Al-Awqati Q. 1995. Regulation of ion channels by ABC transporters that secrete ATP. Science 269:805-806.
2. Arnett TR, King BF. 1997. ATP as an osteoclast regulator? J Physiol (Lond) 503:236.
3. Bennett WD, Olivier KN, Zeman KL, Hohneker KW, Boucher RC, Knowles MR. 1996. Effect of uridine 5′-triphosphate plus amiloride on mucociliary clearance in adult cystic fibrosis. Am J Respir Crit Care Med 153:1796-1801.
4. Blanchard DK, McMillen S, Djeu JY. 1991. IFN-γ enhances sensitivity of human macrophages to extracellular ATP-mediated lysis. J Immunol 147:2579-2585.
5. Born GVR, Kratzer MAA. 1984. Source and concentration of extracellular adenosine triphosphate during haemostasis in rats, rabbits and man. J Physiol (Lond) 354:419-429.
6. 2U purinoceptor present in osteoclastoma, bone, and osteoblasts. J Bone Miner Res 10:1137-1145.
7. Bowler WB, Littlewood-Evans A, Bilbe G, Gallagher JA, Dixon CJ. 1998a. P2Y2 receptors are expressed by human osteoclasts of giant cell tumor but do not mediate ATP-induced bone resorption. Bone 22:195-200.
8. Bowler WB, Tattersall JA, Hussein R, Dixon CJ, Cobbold PH, Gallagher JA. 1998b. Release of ATP by osteoblasts: modulation by fluid shear forces. Bone 22(Suppl.):3S (abstract).
9. 2+ mobilization is strongly potentiated by a parathyroid hormone/cAMP-dependent protein kinase pathway independently of mitogen-activated protein kinase. J Biol Chem 274:14315-14324.
10. Burger EH, Klein-Nuleud J. 1999. Mechanotransduction in bone - role of the lacuno-canalicular network. FASEB J 13(Suppl.): S101-112.
11. Burnstock G. 1978. A basis for distinguishing two types of purinergic receptors. In: Straub RW, Bolis L, editors. Cell membrane receptors for drugs and hormones: a multidisciplinary approach. New York: Raven Press, p 107-118.
12. Burnstock G. 1999. Release of vasoactive substances from endothelial cells by shear stress and purinergic mechanosensory transduction. J Anat 194:335-342.
13. 7 purinoceptor by 17β-oestradiol. J Physiol (Lond) 508:659-666.
14. 7 receptor. J Cell Biol 138:697-706.
15. Clarke LL, Boucher RC. 1992. Chloride secretory response to extracellular ATP in human normal and cystic fibrosis nasal epithelia. Am J Physiol 263:C348-C356.
16. Damer S, Niebel B, Czechem S, Nickel P, Ardanuy U, Schmalzing G, Rettinger J, Mutsehler E, Lambrecht G. 1998. NF279: a novel potent and selective antagonist of P2X receptor-mediated responses. Eur J Pharmacol 350:R5-6.
17. Daniel JL, Dangelmaier C, Jin J, Ashby B, Smith JB, Kunapuli SP. 1998. Molecular basis for ADP-induced platelet activation. I. Evidence for three distinct ADP receptors on human platelets. J Biol Chem 273:2024-2029.
18. Di Virgilio F, Chiozzi P, Falzoni S, Ferrari D, Sanz JM, Venketaraman V, Baricordi OR. 1998. Cytolytic P2X purinoceptors. Cell Death Differ 5:191-199.
19. Dixon CJ, Bowler WB, Walsh CA, Gallagher JA. 1997. Effects of extracellular nucleotides on single cells and populations of human osteoblasts: contribution of cell heterogeneity to relative potencies. Br J Pharmacol 120:777-780.
20. Dixon SJ, Kaplan AD, Naemsch LN, Sims SM, Underhill TM, Weidema AF. 1998. P2 purinoceptors in skeletal cells: receptor subtypes, signalling pathways, and possible role in mechanotransduction. In: Davidovitch Z, Mah J, editors. Biological mechanisms of tooth eruption, resorption and replacement by implants. Boston: Harvard Soc Adv Orthodont. p 301-314.
21. 2+ concentration induced by mechanical stimulation is propagated via release of pyrophosphorylated nucleotides in mammary epithelial cells. Pflügers Arch 427:533-542.
22. 1-deficient mice. Nat Med 5:1199-1202.
23. Farsoudi KH, Pietschmann P, Cross HS, Peterlik M. 1993. Suramin is a potent inhibitor of calcemic hormone- and growth factor-induced bone resorption in vitro. J Pharmacol Exp Ther 264:579-583.
24. Ferrier J, Yu H. 1996. Nuclear versus perinuclear and cytoplasmic calcium in osteoclasts. Cell Calcium 20:381-388.
25. Fischer B, Yefidoff R, Major DT, Rutman-Halili I, Shneyvays V, Zinman T, Jacobson K A, Shainberg A. 1999. Characterization of "mini-nucleotides" as P2X receptor agonists in rat cardiomyocyte cultures. An integrated synthetic, biochemical, and theoretical study. J Med Chem 42:2685-2696.
26. Fisher JE, Rogers MJ, Halasy JM, Luckman SP, Hughes DE, Masarachia PJ, Wesolowski G, Russell RG, Rodan GA, Reszka AA. 1999. Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro. Proc Natl Acad Sci USA 96:133-138.
27. Frith JC, Mönkkönen J, Blackburn GM, Russell RGG, Rogers MJ. 1997. Clodronate and liposome-encapsulated clodronate are metabolized to a toxic ATP analog, adenosine 5'-(β,γ-dichloromethylene) triphosphate, by mammalian cells in vitro. J Bone Miner Res 12:1358-1367.
28. 2U signaling pathways. J Cell Physiol 162:305-314.
29. 7 receptors expressed by human osteoclastoma modulates bone resorption. Calcif Tissue Int 64(Suppl. 1):S56 (abstract).
30. i transients and oscillations in mouse fibroblasts are mediated by endogenously released ATP. J Biol Chem 270:4451-4456.
31. Grigoriadis AE, Schellander K, Wang ZQ, Wagner EF. 1993. Osteoblasts are target cells for transformation in c-fos transgenic mice. J Cell Biol 122:685-701.
32. Grygorczyk R, Hanrahan JW. 1997. CFTR-independent ATP release from epithelial cells triggered by mechanical stimuli. Am J Physiol 272:C1058-C1066.
33. Guggino SE, Lajeunesse D, Wagner JA, Snyder SH. 1989. Bone remodeling signaled by a dihydropyridine- and phenylalkylamine-sensitive calcium channel. Proc Natl Acad Sci USA 86:2957-2960.
34. 2-purinergic receptors: subtype-associated signaling responses and structure. Ann Rev Pharmacol Toxicol 35:541-579.
35. Hipskind RA, Bilbe G. 1998. MAP kinase signaling cascades and gene expression in osteoblasts. Front Biosci 3:D804-816.
36. Hoebertz A, Townsend-Nicholson A, Burnstock G, Arnett TR. 1999. Expression of P2 receptors in bone. Bone 25:163 (abstract).
37. 2T-purinoceptors. Br J Pharmacol 113:1057-1063.
38. Huwiler A, Pfeilschifter J. 1994. Stimulation by extracellular ATP and UTP of the mitogen-activated protein kinase cascade and proliferation of rat renal mesangial cells. Br J Pharmacol 113: 1455-1463.
39. Jones SJ, Gray C, Boyde A, Burnstock G. 1997. Purinergic transmitters inhibit bone formation by cultured osteoblasts. Bone 21:393-399.
40. Jørgensen NR, Geist ST, Civitelli R, Steinberg TH. 1997. ATP- and gap junction-dependent intercellular calcium signaling in osteoblastic cells. J Cell Biol 139:497-506.
41. 2+, but not cyclic adenosine 3', 5'-monophosphate response to parathyroid hormone in rat osteoblastic cells. Endocrinology 136:1674-1685.
42. Kelly MEM, Dixon SJ, Sims SM. 1992 Inwardly rectifying potassium current in rabbit osteoclasts: a whole-cell and single-channel study. J Membr Biol 126:171-181.
43. Kelly MEM, Dixon SJ, Sims SM. 1994. Outwardly rectifying chloride current in rabbit osteoclasts is activated by hyposmotic stimulation. J Physiol (Lond) 475:377-389.
44. Klein-Nulend J, Raisz LG. 1989. Effects of two inhibitors of anion transport on bone resorption in organ culture. Endocrinology 125:1019-1024.
45. Kumagai H, Sakamoto H, Guggino S, Filburn CR, Sacktor B. 1989. Neurotransmitter regulation of cytosolic calcium in osteoblast-like bone cells. Calcif Tissue Int 45:251-254.
46. Kumagai H, Sacktor B, Filburn CR. 1991. Purinergic regulation of cytosolic calcium and phosphoinositide metabolism in rat osteoblast-like osteosarcoma cells. J Bone Miner Res 6:697-708.
47. Lazarowski ER, Homolya L, Boucher RC, Harden TK. 1997a. Identification of an ecto-nucleoside diphosphokinase and its contribution to interconversion of P2 receptor agonists J Biol Chem 272:20402-20407.
48. Lazarowski ER, Homolya L, Boucher RC, Harden TK. 1997b. Direct demonstration of mechanically induced release of cellular UTP and its implication for uridine nucleotide receptor activation. J Biol Chem 272:24348-24354.
49. 3 receptor subunits can account for ATP-gated currents in sensory neurons. Nature 377:432-435.
50. Lustig KD, Shiau AK, Brake AJ, Julius D. 1993. Expression cloning of an ATP receptor from mouse neuroblastoma cells. Proc Natl Acad Sci USA 90:5113-5117.
51. MacKenzie AB, Surprenant A, North RA. 1999. Functional and molecular diversity of purinergic ion channel receptors. Ann NY Acad Sci 868:716-729.
52. Maier R, Glatz A. Mosbacher J, Bilhe G. 1997. Cloning of P2Y6 cDNAs and identification of a pseudogene: comparison of P2Y receptor subtype expression in bone and brain tissues. Biochem Biophys Res Commun 237:297-302.
53. Milner P, Bodin P, Loesch A, Burnstock G. 1990. Rapid release of endothelin and ATP from isolated aortic endothelial cells exposed to increased flow. Biochem Biophys Res Commun 170:649-656.
54. 4-: elimination of osteoclasts, macrophages, and their precursors from isolated bone cell populations and fetal bone rudiments. Calcif Tissue Int 55:141-150.
55. Morrison MS, Turin L, King BF, Burnstock G, Arnett TR. 1998. ATP is a potent stimulator of the activation and formation of rodent osteoclasts. J Physiol (Lond) 511:495-500.
56. 4 purinoceptors mediate an ATP-activated, non-selective cation current in rabbit osteoclasts. J Cell Sci 112:4425-4435.
57. 1 purinergic receptors in sensory neurons: contribution to touch-induced impulse generation. Proc Natl Acad Sci USA 93:10465-10470.
58. Neary JT, Whittemore SR, Zhu Q, Norenberg MD. 1994. Synergistic activation of DNA synthesis in astrocytes by fibroblast growth factors and extracellular ATP. J Neurochem 63:490-494.
59. Parkinson N, Bolsover S, Mason W. 1998. Nuclear and cytosolic calcium changes in osteoclasts stimulated with ATP and integrin-binding peptide. Cell Calcium 24:213-221.
60. Ralevic V, Burnstock G. 1998. Receptors for purines and pyrimidines. Pharmacol Rev 50:413-492.
61. Rassendren F, Buell G, Newbolt A, North RA, Surprenant A. 1997. Identification of amino acid residues contributing to the pore of a P2X receptor. EMBO J 16:3446-3454.
62. i in rat osteoblastic cells by interaction with two receptor subtypes. Am J Physiol 263:C1040-C1048.
63. Roman RM, Wang Y, Lidofsky SD, Feranchak AP, Lomri N, Scharschmidt BF, Fitz JG. 1997. Hepatocellular ATP-binding cassette protein expression enhances ATP release and autocrine regulation of cell volume. J Biol Chem 272:21970-21976.
64. Russell RGG, Rogers MJ. 1999. Bisphosphonates: from the laboratory to the clinic and back again. Bone 25:97-106.
65. 2-purinoceptors on human osteoblast-like cells. J Bone Miner Res 7:485-491.
66. Shimegi S. 1996. ATP and adenosine act as a mitogen for osteoblast-like cells (MC3T3-E1). Calcif Tissue Int 58:109-113.
67. 2U purinergic receptors with similar second messenger signaling pathways in UMR-106 osteoblasts. J Pharmacol Exp Ther 269:1049-1061.
68. 2 purinergic receptors potentiate parathyroid hormone receptor-mediated increases in intracellular calcium and inositol trisphosphate in UMR-106 rat osteoblasts. Endocrinology 136:4489-4497.
69. 7). Science 272:735-738.
70. 2 is a potential mediator of extracellular ATP action in osteoblast-like cells. Cell Adhes Commun 1:113-118.
71. Suzuki A, Shinoda J, Oiso Y, Kozawa O. 1995. Mechanism of phospholipase D activation induced by extracellular ATP in osteoblast-like cells. J Endocrinol 145:81-86.
72. Torres GE, Egan TM, Voigt MM. 1999a. Hetero-oligomeric assembly of P2X receptor subunits. Specificities exist with regard to possible partners. J Biol Chem 274:6653-6659.
73. Torres GE, Egan TM, Voigt MM. 1999b. Identification of a domain involved in ATP-gated ionotropic receptor subunit assembly. J Biol Chem 274:22359-22365.
74. Walther MM, Kragel PJ, Trahan E, Venzon D, Blair HC, Schlesinger PH, Jamai-Dow C, Ewing MW, Myers CE, Linchan WM. 1992. Suramin inhibits bone resorption and reduces osteoblast number in a neonatal mouse calvarial bone resorption assay. Endocrinology 131:2263-2270.
75. Watanabe-Tomita Y, Suzuki A, Shinoda J, Oiso Y, Kozawa O. 1997. Arachidonic acid release induced by extracellular ATP in osteoblasts: role of phospholipase D. Prostaglandins Leukot Essent Fatty Acids 57:335-339.
76. 2 receptors in airway epithelia. J Biol Chem 273:14053-14058.
77. + channels in rat osteoclasts. J Physiol (Lond) 503:303-315.
78. Weidema AF, Dixon SJ, Sims SM. 1998. Ion channels in osteoclasts. In: Zaidi M, editor. Advances in organ biology, vol. 5B. Molecular and cellular biology of bone. Stamford, CA: JAI Press, p 423-442.
79. Wiebe SH, Sims SM, Dixon SJ. 1999. Calcium signalling via multiple P2 purinoceptor subtypes in rat osteoclasts. Cell Physiol Biochem 9:323-337.
80. 4 that mediates chemotaxis. Nature 387:620-624.
81. Yoneda T, Williams P, Rhine C, Boyce BF, Dunstan C, Mundy GR. 1995. Suramin suppresses hypercalcemia and osteoclastic bone resorption in nude mice bearing a human squamous cancer. Cancer Res 55:1989-1993.
82. Yu H, Ferrier J. 1993a. Osteoblast-like cells have a variable mixed population of purino/nucleotide receptors. FEBS Lett 328:209-214.
83. Yu H, Ferrier J. 1993b. ATP induces an intracellular calcium pulse in osteoclasts. Biochem Biophys Res Commun 191:357-363.
84. 2+ signaling in osteoclasts. Cell Signal 6:905-914.
85. Yu H, Ferrier J. 1995. Osteoclast ATP receptor activation leads to a transient decrease in intracellular pH. J Cell Sci 108:3051-3058.
86. Zheng LM, Zychlinsky A, Liu CC, Ojcius DM, Young JD. 1991. Extracellular ATP as a trigger for apoptosis or programmed cell death. J Cell Biol 112:279-288.